Previous Close | 2.3000 |
Open | 2.3000 |
Bid | 2.1900 x 600 |
Ask | 2.2200 x 700 |
Day's Range | 2.1500 - 2.5292 |
52 Week Range | 1.3200 - 3.9700 |
Volume | |
Avg. Volume | 918,337 |
Market Cap | 560.861M |
Beta (5Y Monthly) | -0.56 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have significant influence over...
Does Lyell Immunopharma (LYEL) have what it takes to be a top stock pick for momentum investors? Let's find out.
LYEL Advances Solid Tumor Cell Therapy Pipeline with Strong Cash Position into 2027